Background/Objectives: N-3 (omega-3) fatty acids have been reported to decrease the risk for development of b-cell autoimmunity and clinical type I diabetes. We set out to examine whether different serum fatty acids are associated with the development of advanced b-cell autoimmunity in children carrying human leukocyte antigen DQ b-1 (HLA-DQB1)-conferred susceptibility to type I diabetes. Subjects/Methods: Within a cohort, serum total fatty acid composition of 108 children with advanced b-cell autoimmunity and of 216 matched persistently autoantibody-negative controls was analyzed using gas chromatography. Non-fasting serum samples were obtained annually at the ages of 1-6 years. Conditional logistic regression was applied to analyze the associations between advanced b-cell autoimmunity and serum fatty acids. Results: The serum fatty acid profile of myristic acid (odds ratio (OR) 1.48, 95% confidence interval (CI) 1.09-2.00, P ¼ 0.011), pentadecanoic acid (OR 1.65, 95% CI 1.19-2.28, P ¼ 0.003), palmitoleic acid isomers 16:1 n-7 (omega-7) (OR 1.41, 95% CI 1.03-1.92, P ¼ 0.030) and 16:1 n-9 (omega-9) (OR 1.45, 95% CI 1.05-2.01, P ¼ 0.026) and conjugated linoleic acid (OR 1.67, 95% CI 1.16-2.41, P ¼ 0.006) closest to the time of the appearance of multiple autoantibodies were positively associated with the risk of advanced b-cell autoimmunity after adjustment for potential confounding factors. Serum linoleic acid showed inverse, marginal association with the end point. Conclusions: Serum biomarkers of milk and ruminant meat fat consumption are directly associated and linoleic acid is inversely associated with advanced b-cell autoimmunity in children with HLA-conferred susceptibility to type I diabetes.
Introduction
Experimental studies in cell cultures, animals and humans indicate that fatty acids may modulate the functions of the immune system (Hughes et al., 1996; Kleemann et al., 1998; Wallace et al., 2001; Kew et al., 2004; Fritsche, 2006) . Consequently, fatty acids might affect the development of type I diabetes, which results from an autoimmune inflammatory destruction of the insulin-producing b cells. So far, only a few studies have addressed the possible role of fatty acids in the development of type I diabetes. Studies in rats suggest that long-chain fatty acids are able to prevent alloxan-induced diabetes (Mohan and Das, 2001; Suresh and Das, 2001) . Consumption during the first year of life of cod liver oil, which is rich in n-3 (omega-3) fatty acids, was associated with a reduced risk of type I diabetes in a case-control study (Stene and Joner, 2003) . In a cohort of children with increased genetic risk for type I diabetes, the total intake of n-3 fatty acids and their content in erythrocyte membranes was inversely associated with b-cell autoimmunity characterizing pre-type I diabetes (Norris et al., 2007) . However, the putative effects of other fatty acids on type I diabetes development have not been evaluated in humans. Certain fatty acids function as biomarkers of milk and ruminant meat fat intake (Wolk et al., 2001) , and essential fatty acids in serum reflect vegetable oil consumption (Zock et al., 1997 ). Cow's milk intake during infancy and childhood has been linked to development of type I diabetes (for example, Virtanen et al., 1991; Verge et al., 1994; Virtanen et al., 2000) . We aimed at examining, in a birth cohort of children carrying increased human leukocyte antigen DQ b-1 (HLA-DQB1)-conferred risk for type I diabetes, what fatty acids in serum show association with the development of advanced b-cell autoimmunity, that is, positivity for islet cell autoantibodies (ICAs) and at least one other autoantibody out of the three additional antibodies commonly analyzed for predictive purposes.
Subjects and methods

Study design
Within a large prospective, population-based birth cohort of Finnish children at increased genetic risk for type I diabetes in the Type 1 Diabetes Prediction and Prevention Study (DIPP), serum fatty acids were analyzed in 108 children developing advanced b-cell autoimmunity or type I diabetes (cases) and 216 persistently autoantibody-negative control children (controls). The high-risk genotype was defined as HLA-DQB1*02/*0302 and moderate-risk genotypes as HLA-DQB1*0302/x; with x ¼ other than *02, *0301 or *0602). The children were born between 1 October 1996 and 6 July 2004 in Oulu and Tampere University Hospitals (n ¼ 5787, 76% of the children invited). Ethical approval has been obtained from the local Ethics Committees. A written informed consent was obtained from the parent(s). A detailed description of the genetic screening methods and enrolment criteria in the DIPP Study have been published (Kupila et al., 2001) . DIPP Study has been registered in www.clinicaltrials.gov (NCT00223613).
The DIPP children were monitored for the appearance of signs of b-cell autoimmunity by analyzing primarily ICA. If a child tested positive for ICA, all his or her samples obtained since birth were analyzed for autoantibodies to insulin, antibodies to the 65 kD of glutamic acid decarboxylase and the tyrosine phosphatase-related IA-2molecule. Autoantibody samples were obtained at each study center visit scheduled to take place at the ages of 3, 6, 12, 18 and 24 months, and subsequently at an interval of 12 months. If the child turned positive for ICA, the visit interval was shortened to 3 months. The autoantibodies were analyzed in the Research Laboratory, Department of Pediatrics, University of Oulu as described in Kukko et al. (2005) .
We defined advanced b-cell autoimmunity as being repeatedly positive for ICA and for one or more of the three other antibodies analyzed. By 30 September 2004, among the 5787 children enrolled in DIPP in Oulu and Tampere, 119 (2.1%) tested repeatedly positive for ICA and at least one other autoantibody. By November 2004, 45 (0.8%) children had progressed to clinical type I diabetes at a median age of 3.1 years (range 1.0-6.4 years). Clinical type I diabetes was included in the autoantibody end point as described in Uusitalo et al. (2008) . This resulted in 128 children (2.2% of all children) with either clinical type I diabetes or repeated positivity for ICA and at least one other autoantibody. The term 'advanced b-cell autoimmunity' (multiple seroconversion) will be used to describe jointly these two groups of children.
For each case, two controls matched for gender, genetic risk group, site and time of birth (range ±3 months) were selected as described in Uusitalo et al. (2008) . Sociodemographic factors and familial diabetes were registered by a structured questionnaire completed by the parents after the delivery. We obtained data on neonatal and pregnancy characteristics from the Medical Birth Registries at Oulu and Tampere University Hospitals (Table 1 ). The children were measured for length/height and weight during the study center visits. Body mass index (BMI) was calculated as the ratio of weight to height 2 . Non-fasting serum samples for fatty acid analyses were taken annually by venipuncture, protected from light and stored at À70 1C (Uusitalo et al., 2008) . The samples from each case-control set were taken for analysis until the time when the case child progressed to advanced b-cell autoimmunity. Of the 128 case children, 20 were excluded because no serum samples were available. Consequently, serum fatty acids of 108 cases and 216 controls were analyzed. On the average, two serum samples were available from each child. All samples from each case-control set were measured in the same batch by a bioanalyst who was blinded for the case-control status of the children.
We determined serum fatty acids as follows. Fat was extracted from 50 ml of serum with dichloromethanemethanol (2:1, volume/volume) (Folch et al., 1957) . Total fatty acids were methylated with acidic (5% weight H 2 SO 4 ) methanol (Stoffel et al., 1959) . The percentage composition of methylated total fatty acids from 14:0 to 22:6 n-3 was determined using the HP 6890 gas chromatograph (Hewlett Packard, Palo Alto, CA, USA) equipped with Chemstation (version A.06.03) having a DB225 column (30-m long I.D. 0.32 mm, phase layer 0.25 mm, Agilent J&W, Agilent Technologies, Espoo, Finland), using split injection and hydrogen as carrier gas. A temperature program from 160 to 230 1C was used. The percentage composition of fatty acid methyl esters was normalized to 100%. Between-series variability of control samples was 2-7% for fatty acid peaks over 1% and 6-18% for smaller peaks. We determined altogether 17 individual fatty acids and, in addition, calculated palmitoleic to palmitic acid ratio, which reflects stearoyl-CoA desaturase activity. The fatty acids were expressed as percentages of total fatty acids in serum (Table 2) . Serum cholesterol concentrations were analyzed manually in the Laboratory of Analytical Biochemistry by an Olli-C photometer (Thermo Fisher Scientific, Vantaa, Finland) using an enzymatic cholesterol oxidase (phenol, 4-aminoantipyrine) method.
Statistical analysis
The estimation of risk is based on a nested case-control design set up within the cohort. In a nested case-control design each case is associated with k randomly selected matched controls (in the present study, k ¼ 2). The standard procedure of estimation in nested case-control designs is the conditional likelihood logistic regression analysis (Borgan and Samuelsen, 2003) . This approach yields consistent and asymptotically normal estimates of the regression parameters (Borgan et al., 1995) . We used SAS version 9.1.3 (SAS Institute, Cary, NC, USA) PROC LOGISTIC with the strata-option to fit the models. Statistical significance was taken as 5%. The differences between cases and controls in the background characteristics were tested with the Wald test obtained from the conditional likelihood analysis of logistic regression.
The number of measurements per child is small and does not, at this early stage of the follow-up, permit the use of multiple lagged covariates models. Because of this exploratory nature of the analysis approach, it is important to investigate the changes in point estimates (odds ratios (ORs)) across different choices of time lags. The end point analyses were performed in three settings. First, the serum fatty acid composition at 1 year of age (the first measurement) was used as the explanatory variable. Second, the nearest fatty acid profile at least 0.5 year before the appearance of advanced b-cell autoimmunity was applied. Third, the most recent available single measurement value for fatty acid composition at or before the time when the case turned out to have advanced b-cell autoimmunity was used. To remove potential time trends in the serum fatty acid composition during early childhood, we computed the z-scores of the measurements within each time point before the analysis and used these in the model. The associations were studied both on continuous and categorical scales (the latter defined by falling into intervals given by the first and the third sample quartile within each age group). Because no suggestion for nonlinearity of the associations was observed, only the results for the continuous fatty acid variables are presented.
Results
The serum fatty acids consisted mainly of oleic, linoleic and palmitic acids in both case and control children. For example, at the age of 1 year, in the serum of the controls, linoleic acid represented 27.2%, arachidonic acid 5.2%, other n-6 polyunsaturated fatty acids 1.7%, n-3 polyunsaturated fatty acids 3.8%, oleic acid 27.2%, other monounsaturated Serum fatty acids and risk of pre-type I diabetes SM Virtanen et al OR, odds ratio.
In the analyses the risk has been explained for each individual of the case-control set by the fatty acid composition. Odds ratio (OR) describes change in risk, when fatty acid composition is changed by an amount corresponding to its s. age, duration of gestation, type I diabetes in a first-degree relative, number of earlier deliveries and maternal smoking during pregnancy.
f Palmitoleic to palmitic acid ratio reflects stearoyl-CoA desaturase activity.
g Total n-6 fatty acids is calculated as sum of linoleic acid, arachidonic acid, g-linolenic acid and dihomo-g-linolenic acid, and total n-3 fatty acids is calculated as sum of a-linolenic acid, eicosapentaenoic acid, docosahexaenoic acid and docosapentaenoic acid.
h Sum of isomers 10-trans, 12-cis-18:2 and 9-cis, 11-trans-18:2. *Po0.05; the statistically significant (Po0.05) findings are in bold. **Po0.01; the statistically significant (Po0.05) findings are in bold.
fatty acids plus conjugated linoleic acid 3.9%, palmitic acid 21.6% and other saturated fatty acids 9.4% of the total fatty acids. Figure 1 shows the distribution of myristic acid, pentadecanoic acid and linoleic acid at 1 year of age, and in the most recent measurement in case and control children. The ORs from different time lags reveal that the effect tends to increase in magnitude the closer the measurement is to the time of seroconversion. At or closest before the appearance of multiple autoantibodies, the proportions of myristic acid and pentadecanoic acid were significantly associated with an increased risk for advanced b-cell autoimmunity (Table 2 ). These associations were strengthened when the models were adjusted for the listed confounding factors. In an adjusted model, the proportion of palmitoleic acid isomers 16:1 n-7 and 16:1 n-9, and that of the conjugated linoleic acid isomers were also significantly associated with an increased risk of advanced b-cell autoimmunity as was the ratio of palmitoleic acid to palmitic acid. A nearly significant inverse association was observed between the risk of advanced b-cell autoimmunity and the proportions of linoleic acid (P ¼ 0.051) in serum in the adjusted model. In the cholesterol-adjusted model, the inverse association between the risk of advanced b-cell autoimmunity and the proportion of linoleic acid became significant (linoleic acid OR 0.68, 95% confidence interval (CI) 0.48-0.96, P ¼ 0.028). Interestingly, the estimated effect of linoleic acid, although marginal, seems to be invariant to the choice of the time lag used in the analysis. Adjusting for cholesterol did not change the other associations (data not shown).
The BMI of the children at 1 year of age, at least 0.5 year before or at the time of the appearance of advanced b-cell autoimmunity, was not related to the end point (OR 1.13, 95% CI 0.96-1.35, OR 1.11, 95% CI 0.89-1.39 and OR 1.09, 95% 0.92-1.30, respectively). The serum fatty acid pattern was associated with BMI. At the age of 1 year, serum stearic (r ¼ À0.125), eicosapentaenoic (r ¼ À0.125), docosahexaenoic (r ¼ À0.155) and arachidonic acid (r ¼ À0.127) were inversely correlated with BMI at the same age (Po0.05). At the time of the appearance of advanced b-cell autoimmunity, positive correlations were observed between myristic (r ¼ 0.169), palmitic (r ¼ 0.225) and oleic acid (r ¼ 0.148) and BMI at the same time and inverse correlations between serum stearic (r ¼ À0.127), eicosapentaenoic (r ¼ À0.199), docosahexaenoic (r ¼ À0.247), docosapentaenoic (r ¼ À0.117), linoleic acid (r ¼ À0.113) and arachidonic acid (r ¼ À0.217). When adjusted for BMI, the associations observed between serum fatty acids and advanced b-cell autoimmunity remained mostly unchanged; at the time of the appearance of advanced b-cell autoimmunity, the associations between myristic, palmitoleic acid (both n-7 and n-9) and the ratio of palmitoleic acid (n-7) to palmitic acid became of borderline significance (Table 2) .
Discussion
We observed among 315 children carrying HLA-conferred susceptibility to type I diabetes that the profiles of individual saturated serum fatty acids, myristic acid and pentadecanoic acid and monounsaturated palmitoleic acid isomers 16:1 n-7 and 16:1 n-9 as well as the two polyunsaturated fatty acid isomers, jointly called conjugated linoleic acid, were positively associated with the risk of advanced b-cell autoimmunity at or before the time of seroconversion. These serum fatty acids are excellent biomarkers of the dietary intake of milk or meat fat of the ruminants (Wolk et al., 2001) . On the other hand, linoleic acid, which reflects vegetable oil intake (Zock et al., 1997) , was inversely associated with the risk of advanced b-cell autoimmunity.
One of the strengths of this study is the population-based nested case-control design, in which the results are not influenced by selection bias. Furthermore, the serum Figure 1 Composition of myristic acid, pentadecanoic acid and linoleic acid in serum in case (circles, mean values) and control (triangles, mean values) children at the age of 1 year (a) and closest to the time of the appearance of advanced b-cell autoimmunity (b). The central bar in the box plots represents the median concentration, the box represents the interquartile range (IQR) and the whiskers represent the smallest and largest non-outlier concentrations. The asterisks represent outliers, that is, observations that lie 41.5 Â IQR lower than the first quartile or 1.5 Â IQR higher than the third quartile. For statistical testing between cases and controls, see columns for unadjusted odds ratios in Table 2 .
samples of the cases and controls were collected, handled, stored and analyzed in the same standardized way.
A limitation of this study was that only one non-fasting serum sample at each age point was available, and also that the total fatty acid composition was determined instead of analyzing fatty acids in isolated lipid fractions. The daily intra-individual variation is more marked in the fatty acid profile of triglycerides and free fatty acids than in the fatty acid profile of cholesterol esters and phospholipids (Moilanen, 1987) . The lipid fractions in serum differ in their fatty acid composition (Nikkari et al., 1983; Moilanen, 1987) and changes in relative proportions of lipid fractions also affect the percentages of fatty acids in serum. For this reason we applied a separate statistical model, which was adjusted for serum cholesterol concentration. We observed an inverse association between the risk of b-cell autoimmunity and linoleic acid composition in serum. This result is in line with the finding that serum biomarkers of milk and meat fat were associated with an increased risk of advanced b-cell autoimmunity, as linoleic acid profile is low if the profile of saturated fatty acids is high. The observation could also reflect that the effect of linoleic acid on advanced b-cell autoimmunity may be protective in accordance with some experimental animal studies (Mohan and Das, 2001; Suresh and Das, 2001) .
Statistical analyses were performed in three settings: first, using fatty acid measurements from 1 year of age (the first age point available); second, at least 0.5 years before the appearance of multiple autoantibodies; and third, using the most recent measurement in relation to the appearance of advanced b-cell autoimmunity. Our findings suggest that the associations observed between fatty acids and advanced b-cell autoimmunity become clearer the closer the time of seroconversion you are. We cannot exclude that the seroconversion to positivity for multiple autoantibodies could affect the serum fatty acid pattern, although we are not aware of any putative mechanism for such an association. It is also possible that the type of fat in the diet might act rather as a promoter than as an initiator of b-cell destruction.
Unlike Norris et al. (2007) who in their case-cohort analysis found 35 children repeatedly positive for at least one autoantibody, we did not observe any association between autoimmunity and the n-3 fatty acid status among the children studied. Most likely, the discrepancy in results is caused by different methods used for the assessment of fatty acid status. The fatty acid composition of erythrocyte membranes describes the intake of n-3 fatty acids over a period of 4-6 weeks (Baur et al., 2000) , whereas our method reflects the intake during the preceding 1 to 2 weeks (Moilanen, 1987; Katan et al., 1997; Arab, 2003) . An important source of n-3 fatty acids in the diet is fatty fish, which is consumed rather rarely by young children (Ylönen et al., 1996) . Therefore, a long-term biomarker of n-3 fatty acid intake is probably more suitable for the estimation of their intake than a short-term biomarker. The mean age of the cases was higher in the previous than in the present study (5.3 vs 2.5 years, respectively). Because the intake of n-3 fatty acids increases with age in children, this difference in age may partly explain our failure to confirm this suggested protective association. On the other hand, milk products and meat are frequently consumed by children (Ylönen et al., 1996) , and thus the determination of serum total fatty acids should reflect their consumption rather well.
All the fatty acids that were positively associated with advanced b-cell autoimmunity in this study reflect dietary intake of milk and/or meat fat of ruminants (Wolk et al., 2001; Crowe et al., 2006) . Especially pentadecanoic and conjugated linoleic acid are not available from other dietary sources and the amounts of them available from ruminant meat compared with milk are very small. A major part of palmitoleic acid 16:1 n-7 is endogenously formed from the desaturation of palmitic acid (Crowe et al., 2006) , and thus the content of palmitoleic acid in serum may reflect intake of palmitic acid from cow's milk and meat.
In previous studies, early introduction of cow's milk in infancy has been linked to the development of preclinical and clinical type I diabetes (Virtanen et al., 1991; Å kerblom et al., 2005) . Findings from the randomized double-blind pilot trial suggest that the appearance of type I diabetesassociated autoantibodies can possibly be reduced by 40-60% by weaning high-risk infants to a highly hydrolyzed formula (Å kerblom et al., 2005) . In addition, the amount of cow's milk used later in childhood could be related to the risk of type I diabetes (Verge et al., 1994; Virtanen et al., 2000; Wahlberg et al., 2006) . It has been suggested that either milk proteins or insulin in milk might trigger the immunization leading to type I diabetes (Vaarala et al., 1999; Schrezenmeir and Jagla, 2000) However, until now there is no unequivocal evidence for a mechanism or for the fraction of milk that possibly facilitates progression to type I diabetes.
Our findings in the area of pre-type I diabetes resemble associations observed between fatty acids and insulin resistance, obesity and type II diabetes. Long-chain unsaturated fatty acids have been associated inversely and saturated fatty acid positively with insulin resistance and obesity (Innis, 2007; Sabin et al., 2007; Aguilera et al., 2008) . Plasma palmitoleic (n-7) content and stearoyl-CoA desaturase activity (ratio of palmitoleic to palmitic acid) were positively associated with abdominal obesity in children (Okada et al., 2005) and in the present series with advanced b-cell autoimmunity. Whether our finding is explained through increased weight gain in childhood and its association with the development of type I diabetes remains to be evaluated. Adjustment for BMI had a minor effect on the associations between serum fatty acids and the autoimmunity end point. If increased weight gain would be involved in the causal pathway between serum fatty acids and autoimmunity, this adjustment would not be justified. The fact that the associations observed between certain fatty acids and advanced b-cell autoimmunity remain after adjustment for BMI, speaks in favor of independent associations between these fatty acids and the end point.
In conclusion, our results suggest that serum biomarkers of milk and meat fat are positively associated and serum linoleic acid is inversely associated with an increased risk of advanced b-cell autoimmunity in children with HLA-conferred susceptibility to type I diabetes. Further research is needed to confirm or contest these associations.
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